tiprankstipranks
Advertisement
Advertisement
Speculative Buy on Turn Therapeutics: Proprietary Platform, Capital-Efficient Growth, and 2026 Milestones as Key Upside Catalysts
PremiumRatingsSpeculative Buy on Turn Therapeutics: Proprietary Platform, Capital-Efficient Growth, and 2026 Milestones as Key Upside Catalysts
2M ago
Turn Therapeutics Issues Corporate, Pipeline and Financial Updates
Premium
Company Announcements
Turn Therapeutics Issues Corporate, Pipeline and Financial Updates
2M ago
Turn Therapeutics appoints veteran executive to board
Premium
Company Announcements
Turn Therapeutics appoints veteran executive to board
3M ago
Turn Therapeutics Appoints New VP of Communications
PremiumCompany AnnouncementsTurn Therapeutics Appoints New VP of Communications
5M ago
Turn Therapeutics Partners with Medline for Global Expansion
Premium
Company Announcements
Turn Therapeutics Partners with Medline for Global Expansion
5M ago
Turn Therapeutics enters global supply, license agreement with Medline
Premium
The Fly
Turn Therapeutics enters global supply, license agreement with Medline
5M ago
Turn Therapeutics appoints Kester to board of directors
PremiumThe FlyTurn Therapeutics appoints Kester to board of directors
5M ago
Turn Therapeutics files to sell 7M shares off common stock for holders
Premium
The Fly
Turn Therapeutics files to sell 7M shares off common stock for holders
6M ago
Turn Therapeutics Inc. Common Stock trading resumes
Premium
The Fly
Turn Therapeutics Inc. Common Stock trading resumes
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100